100929-55-3 ((TYR-D-ALA-GLY-PHE-LEU-NH2 ACETATE SALT)

TYR-D-ALA-GLY-PHE-LEU-NH2 ACETATE SALT;acetic acid,(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanamide;(S)-2-((S)-2-(2-((R)-2-((S)-2-amino-3-(4-hydroxyphenyl)propanamido)propanamido)acetamido)-3-phenylpropanamido)-4-methylpentanamide acetate;DTXSID60745622;[D-Ala2]-Leucine enkephalinamide acetate salt, >=95% (HPLC);CHEMBL2372197;Acetic acid--L-tyrosyl-D-alanylglycyl-L-phenylalanyl-L-leucinamide (1/1);BDBM50027508;D-ALA-2-LEUCINE ENKEPHALINAMIDE ACETATE;100929-55-3;(D-alanine2)leucine enkephalinamide;[D-ALA2]-LEUCINE ENKEPHALINAMIDE ACETATE SALT;

CQOMFFDBVNJVDP-KBUZRCILSA-N

1S/C29H40N6O6.C2H4O2/c1-17(2)13-23(26(31)38)35-29(41)24(15-19-7-5-4-6-8-19)34-25(37)16-32-27(39)18(3)33-28(40)22(30)14-20-9-11-21(36)12-10-20;1-2(3)4/h4-12,17-18,22-24,36H,13-16,30H2,1-3H3,(H2,31,38)(H,32,39)(H,33,40)(H,34,37)(H,35,41);1H3,(H,3,4)/t18-,22+,23+,24+;/m1./s1

O=C([C@H](CC1C=CC=CC=1)NC(CNC([C@@H](C)NC([C@H](CC1C=CC(=CC=1)O)N)=O)=O)=O)N[C@H](C(N)=O)CC(C)C.OC(C)=O